AIM • KMU EXAM REASONING

Question:

A 57-year-old woman with inflammatory arthritis has persistent morning stiffness and progressive joint deformity despite adequate symptomatic pain control with an NSAID. Her physician explains that another group of drugs is needed to slow structural disease progression. Which therapeutic role best describes this group?

Options:

Correct Answer: Modification of long-term inflammatory disease activity

Explanation: DMARDs are used to reduce chronic inflammatory disease activity and limit structural damage, whereas NSAIDs mainly provide symptomatic relief.

Question:

A 45-year-old man with severe inflammatory disease requires rapid, broad suppression of multiple inflammatory pathways rather than selective cyclooxygenase inhibition. Which drug group best fulfills this role?

Options:

Correct Answer: Glucocorticoids

Explanation: Glucocorticoids suppress inflammation at several levels and have broader anti-inflammatory actions than drugs acting mainly through COX inhibition.

Question:

A 62-year-old man is prescribed aspirin for prevention of platelet aggregation. Which approximate daily dose range is most consistent with this indication?

Options:

Correct Answer: 75–150 mg daily

Explanation: Low-dose aspirin provides antiplatelet activity; substantially larger doses are required for analgesic and especially anti-inflammatory effects.

Question:

A 26-year-old woman takes aspirin for headache and fever. The prescribed dose is substantially higher than the amount used for antiplatelet therapy but far below traditional anti-inflammatory dosing. Which dose range best fits this use?

Options:

Correct Answer: 300–600 mg per dose

Explanation: Analgesic and antipyretic aspirin dosing is typically in the hundreds of milligrams per dose, whereas antiplatelet dosing is much lower.

Question:

A patient with active inflammatory arthritis is told that aspirin requires much larger total daily doses for a sustained anti-inflammatory effect than for prevention of thrombosis. Which explanation best accounts for this difference?

Options:

Correct Answer: Greater systemic COX inhibition is required for anti-inflammatory activity

Explanation: Platelet COX-1 is highly sensitive to low-dose aspirin, while sustained anti-inflammatory effects require much greater systemic drug exposure.

Question:

A patient taking progressively larger doses of aspirin develops a disproportionate rise in plasma salicylate concentration. Which pharmacokinetic change most likely explains this finding?

Options:

Correct Answer: Saturation of metabolic elimination pathways

Explanation: At higher salicylate concentrations, hepatic metabolic pathways become saturated, so elimination becomes less efficient and accumulation becomes disproportionate.

Question:

A 39-year-old woman requires an NSAID for a short painful inflammatory condition. The physician wants a drug with relatively brief systemic persistence rather than a long-acting agent. Which pharmacokinetic profile is most suitable?

Options:

Correct Answer: Relatively short elimination half-life

Explanation: Short-acting NSAIDs such as ibuprofen are useful when brief symptom control is desired and prolonged drug exposure is unnecessary.

Question:

A patient with inflammatory pain is prescribed diclofenac. Although its plasma half-life is relatively short, clinically useful activity persists beyond what might be expected from plasma concentrations alone. Which interpretation best explains this observation?

Options:

Correct Answer: Effective tissue concentrations may outlast the plasma half-life

Explanation: Diclofenac has a short plasma half-life, yet persistence at sites of action can support a clinically useful duration of effect.

Question:

A physician considers indomethacin for a painful inflammatory condition but chooses another NSAID because the patient has several risk factors for drug toxicity. Which property of indomethacin supports this cautious approach?

Options:

Correct Answer: Its potent action is accompanied by limiting adverse effects

Explanation: Indomethacin is a potent NSAID, but its adverse-effect burden limits routine use compared with better-tolerated alternatives.

Question:

A 23-year-old woman is prescribed mefenamic acid for a short-duration painful condition. Which pharmacokinetic characteristic is most consistent with its clinical use?

Options:

Correct Answer: Relatively short action with hepatic metabolism and urinary elimination

Explanation: Mefenamic acid is relatively short acting, is metabolized in the liver and has metabolites eliminated largely through the urine.

Question:

A patient taking an NSAID develops wheezing shortly after a dose. The physician suspects an NSAID-related hypersensitivity reaction rather than direct pulmonary toxicity. Which pharmacological event initiated the reaction?

Options:

Correct Answer: Cyclooxygenase inhibition in a susceptible patient

Explanation: Some susceptible patients develop bronchospasm after NSAID-induced COX inhibition; this is a recognized class-related hypersensitivity phenomenon.

Question:

A patient presents within a clinically relevant interval after ingesting a large amount of aspirin. Before significant systemic deterioration develops, which treatment may reduce further gastrointestinal absorption of the drug?

Options:

Correct Answer: Activated charcoal

Explanation: Activated charcoal can bind aspirin remaining in the gastrointestinal tract and reduce further absorption after an appropriate recent ingestion.

Question:

A patient with salicylate toxicity is being treated with intravenous bicarbonate, but urinary alkalinization remains difficult because serum potassium is low. Which additional measure is important?

Options:

Correct Answer: Correct the potassium deficit

Explanation: Hypokalemia interferes with achieving adequate urinary alkalinization, so potassium correction is an important part of salicylate poisoning treatment.

Question:

A 68-year-old man with osteoarthritis and a previous gastric ulcer is prescribed a COX-2 selective drug. Which pharmacological feature explains why gastric mucosal protection is relatively better preserved?

Options:

Correct Answer: Preferential inhibition of inflammatory COX-2

Explanation: Selective COX-2 inhibitors relatively spare COX-1, allowing greater preservation of COX-1-derived gastric protective prostaglandins.

Question:

A patient taking celecoxib asks whether it can replace low-dose aspirin for prevention of arterial thrombosis because both drugs act on cyclooxygenase enzymes. Which response is pharmacologically correct?

Options:

Correct Answer: Celecoxib lacks useful aspirin-like antiplatelet action

Explanation: Platelet thromboxane synthesis is mainly COX-1 dependent, so selective COX-2 inhibition does not reproduce aspirin’s irreversible antiplatelet effect.

Question:

A 20-year-old student with fever takes a standard therapeutic dose of paracetamol. Most of the absorbed drug follows a metabolic pathway that prevents formation of toxic products. Which process accounts for the major portion of normal metabolism?

Options:

Correct Answer: Hepatic conjugation to non-toxic metabolites

Explanation: At therapeutic doses, most paracetamol undergoes hepatic conjugation to non-toxic products, while only a small fraction forms NAPQI.

Question:

A 30-year-old man asks why paracetamol can reduce fever effectively but is much less useful for marked peripheral inflammatory swelling than ibuprofen. Which explanation best accounts for this difference?

Options:

Correct Answer: Its important prostaglandin effect is predominantly central

Explanation: Paracetamol has clinically important central analgesic and antipyretic actions but weak peripheral anti-inflammatory activity.

Question:

A 52-kg patient is assessed after an acute paracetamol ingestion of 8 g. Which interpretation is most appropriate based on the conventional potentially hepatotoxic threshold?

Options:

Correct Answer: The dose is approximately at a potentially hepatotoxic level

Explanation: A conventional potentially hepatotoxic acute ingestion is about 150 mg/kg; 8 g in a 52-kg patient is approximately 154 mg/kg.

Question:

A patient presents soon after a large paracetamol ingestion. Before hepatic injury becomes established, which intervention may reduce additional drug absorption from the gastrointestinal tract?

Options:

Correct Answer: Activated charcoal

Explanation: Activated charcoal can reduce gastrointestinal absorption after an appropriate recent significant paracetamol ingestion.

Question:

A 29-year-old woman with fever needs an analgesic-antipyretic. She has no inflammatory swelling requiring treatment and wishes to avoid significant gastric mucosal and platelet effects associated with conventional NSAIDs. Which pharmacological profile best matches the preferred drug?

Options:

Correct Answer: Effective analgesic-antipyretic action with weak peripheral anti-inflammatory effect

Explanation: This profile describes paracetamol, which is useful for pain and fever while producing little clinically useful peripheral anti-inflammatory or platelet effect.